Company Analysis

BioRestorative Therapies, Inc. (BRTX)

Nasdaq: BRTX · Services-Misc Health & Allied Services, NEC · Melville, NY · filing with the SEC since 2010
Grade3.5
◀ Past 1.9● Present 3.0▶ Future 5.6
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

7 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to BioRestorative Therapies, Inc.’s names, not what it holds today.

Patents granted
7
7 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against none in 2024 and 2 in 2023
Applications published
10
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'13'14'15'19'20'21'23'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals4
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
BIORESTORATIVE THERAPIES, INC. its own name
US, as the owner printed on each patent
7 granted
3 published
BioRestorative Therapies, Inc. its own name
named as the applicant on its applications, in US
0 granted
7 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 26, 202311,851,682Brown fat cell compositions and methodsPharmaceuticalsBIORESTORATIVE THERAPIES, INC.
Jun 6, 202311,667,892Human brown adipose derived stem cells and usesPharmaceuticalsBIORESTORATIVE THERAPIES, INC.
Jul 20, 202111,066,646Brown fat cell compositions and methodsPharmaceuticalsBIORESTORATIVE THERAPIES, INC.
Mar 9, 202110,941,383Human brown adipose derived stem cells and usesPharmaceuticalsBIORESTORATIVE THERAPIES, INC.
Mar 24, 202010,597,638Brown fat cell compositions and methodsPharmaceuticalsBIORESTORATIVE THERAPIES, INC.
Jan 1, 201910,167,449Human brown adipose derived stem cells and usesPharmaceuticalsBIORESTORATIVE THERAPIES, INC.
Sep 15, 20159,133,438Brown fat cell compositions and methodsPharmaceuticalsBIORESTORATIVE THERAPIES, INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Apr 3, 20252025/0108072NON-NATURALLY OCCURING THREE-DIMENSIONAL (3D) BROWN ADIPOSE-DERIVED STEM CELL AGGREGATES, AND METHODS OF GENERATING AND USING THE SAMEPharmaceuticalsBioRestorative Therapies, Inc.
Oct 7, 20212021/0309972BROWN FAT CELL COMPOSITIONS AND METHODSPharmaceuticalsBioRestorative Therapies, Inc. · patent 11,851,682 granted from it
Jun 10, 20212021/0171914HUMAN BROWN ADIPOSE DERIVED STEM CELLS AND USESPharmaceuticalsBioRestorative Therapies, Inc. · patent 11,667,892 granted from it
Mar 18, 20212021/0077536NON-NATURALLY OCCURING THREE-DIMENSIONAL (3D) BROWN ADIPOSE-DERIVED STEM CELL AGGREGATES, AND METHODS OF GENERATING AND USING THE SAMEPharmaceuticalsBioRestorative Therapies, Inc.
May 9, 20192019/0136194HUMAN BROWN ADIPOSE DERIVED STEM CELLS AND USESPharmaceuticalsBioRestorative Therapies, Inc. · patent 10,941,383 granted from it
Feb 7, 20192019/0040361BROWN FAT CELL COMPOSITIONS AND METHODSPharmaceuticalsBioRestorative Therapies, Inc. · patent 11,066,646 granted from it
Jan 8, 20152015/0010513Human Brown Adipose Derived Stem Cells and UsesPharmaceuticalsBioRestorative Therapies, Inc. · patent 10,167,449 granted from it
Dec 18, 20142014/0370591BROWN FAT CELL COMPOSITIONS AND METHODSPharmaceuticalsBIORESTORATIVE THERAPIES, INC. · patent 9,133,438 granted from it
Jul 31, 20142014/0212875Human Metabolically Active Brown Adipose Derived Stem CellsBiotechnologyBIORESTORATIVE THERAPIES, INC.
Mar 21, 20132013/0071360Brown Fat Cell Compositions and MethodsPharmaceuticalsBIORESTORATIVE THERAPIES, INC.
What it applied for, 2024 to 2025: Pharmaceuticals 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton BRTX · research, not advice